Company intelligence / Profile preview

PharmaTell

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

PharmaTell is an active provider of curated strategic intelligence for the global healthcare sector. It offers access to over 200,000 research reports covering BioPharma, MedTech, Diagnostics, CROs, payers and more. Its proprietary platform—PharmaTell Studio—enables clients to monitor market developments and competitive landscapes in real time. The company does not conduct clinical trials or develop drugs.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Biotechgate/Venture Valuation AG

Beyond the preview

Go deeper on PharmaTell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmaTell.

Explore the full profile